Publications of U. Reichl

Poster (313)

861.
Poster
Nayak, D. P.; Lehmann, S.; Reichl, U.: Downstream Processing of Equine Influenza Virus. International Symposium on Preparative and Industrial Chromatography and Allied Techniques (SPICA 2004), Aachen, Germany (2004)
862.
Poster
Ritter, J. B.; Danova, R.; Genzel, Y.; Reichl, U.: High-Performance Anion-Exchange Chromatography for the Quantitative Analysis of Energy Metabolism in Mammalian Cells. IICS : 17th annual International Ion Chromatography Symposium, Trier, Germany (2004)
863.
Poster
Ritter, J. B.; Danova, R.; Genzel, Y.; Reichl, U.: Identification of parameters relevant for the quantification of intracellular metabolites in mammalian cell culture. ESBES 5, Stuttgart, Germany (2004)
864.
Poster
Ritter, J. B.; Danova, R.; Genzel, Y.; Reichl, U.: Quantitative Analysis of Energy Metabolism in Mammalian Cells. BioPerspectives 2004 (Dechema Jahrestagung), Wiesbaden, Germany (2004)
865.
Poster
Schmidt, J. K.; Schäfer, B.; Geisler, L.; Reichl, U.: Quantitative Mixed Culture Studies with Three Bacterial Species. ESBES 2004 - European Symbosium on Biochemical Engineering Science, Stuttgart, Germany (2004)
866.
Poster
Schwarzer, J.; Wolff, M. W.; Rapp, E.; Schmidt, J. K.; Opitz, L.; Reichl, U.: Glycosylation of Influenza A Virus Hemagglutinin. CCE IX (Cell Culture Engineering IX) 2004, Riviera Maya , Cancun, QR, Mexico (2004)
867.
Poster
Genzel, Y.; Alt, R.; Reichl, U.: Glutamine-free media for vaccine production processes. 18th ESACT Meeting, Granada, Spain (2003)
868.
Poster
Genzel, Y.; Best, C.; Behrendt, I.; König, S.; Sann, H.; Bock, A.; Reichl, U.: Optimization & Scale-up of Bioprocesses: Influenza Vaccine Production in Microcarrier Systems. Bioengineering Course (BEC), Supetar, Croatia (2003)
869.
Poster
Hundt, B.; Reichl, U.: Comparing wave and stirred-tank bioreactor performance for vaccine production with feline lung fibroblasts. 11th Congress on biotechnology, Basel, Switzerland (2003)
870.
Poster
Hundt, B.; Reichl, U.; Schänzler, A.: Serum-free cultivation of CEF for vaccine production in microcarrier-systems. 18th ESACT Meeting, Granada, Spain (2003)
871.
Poster
Möhler, L.; Bock, A.; Sann, H.; Reichl, U.: Mathematical Modeling of MDCK Cell Growth by the Use of On-line Data. DECHEMA Jahrestagung der Biotechnologen, Munich, Germany (2003)
872.
Poster
Sann, H.; Bock, A.; Reichl, U.: Investigation of a new, sterile, deadvolume free sampling-system for universal applications, automated and suitable for online-analyzing. DECHEMA Jahrestagung der Biotechnologen, Munich, Germany (2003)
873.
Poster
Schmidt, J. K.; König, B.; Reichl, U.: Cooperation and competition: studies on heterogeneous microbial cultures. Jahrestagung der Vereinigung für allgemeine und angewandte Mikrobiologie (VAAM), Berlin, Germany (2003)
874.
Poster
Sidorenko, Y.; Sann, H.; Reichl, U.: Structured model of Influenza virus replication in MDCK cells. 11th Congress on biotechnology, Basel, Switzerland (2003)
875.
Poster
Genzel, Y.; Reichl, U.: Analysis of cell growth, virus replication and medium composition in equine influenza vaccine production. IUMS 2002, Paris, France (2002)
876.
Poster
Genzel, Y.; Reichl, U.: Analysis of cell growth, virus replication and medium composition in equine influenza vaccine production. GVC/Dechema Jahrestagungen 2002, Wiesbaden, Germany (2002)
877.
Poster
Genzel, Y.; Voges, L.; Reichl, U.: Development of bioprocess concepts on vaccine production: influenza virus as an example. 17th ESACT Meeting, Tyloesand, Sweden (2001)

Working Paper (3)

878.
Working Paper
Pelz, L.; Rüdiger, D.; Alnaji, F. G.; Genzel, Y.; Brooke, C. B.; Kupke, S. Y.; Reichl, U.: Semi-continuous propagation of influenza A virus and its defective interfering particles: analyzing the dynamic competition to select candidates for antiviral therapy. bioRxiv (2021)
879.
Working Paper
Prerna , A.; Bdeir, N.; Gärtner, S.; Reiter, S.; Pelz, L.; Felgenhauer, U.; Reichl, U.; Ludwig, S.; Weber, F.; Hoffmann, M. et al.; Winkler, M.; Pöhlmann , S.: Interferon induction and not replication interference mainly determines anti-influenza virus activity of defective interfering particles. bioRxiv (2021)
880.
Working Paper
Van Den Bossche, T.; Kunath, B. J.; Schallert, K.; Schäpe, S. S.; Abraham, P. E.; Armengaud, J.; Arntzen, M. Ø.; Bassignani, A.; Benndorf, D.; Fuchs, S. et al.; Giannone, R. J.; Griffin, T. J.; Hagen, L. H.; Halder, R.; Henry, C.; Hettich, R. L.; Heyer, R.; Jagtap, P.; Jehmlich, N.; Jensen, M.; Juste, C.; Kleiner, M.; Langella, O.; Lehmann, T.; Leith, E.; May, P.; Mesuere, B.; Miotello, G.; Peters, S. L.; Pible, O.; Reichl, U.; Renard, B. Y.; Schiebenhoefer, H.; Scryba, A.; Tanca, A.; Trappe, K.; Trezzi, J.-P.; Uzzau, S.; Verschaffelt, P.; von Bergen, M.; Wilmes, P.; Wolf, M.; Martens, L.; Muth, T.: Critical Assessment of Metaproteome Investigation (CAMPI): A Multi-Lab Comparison of Established Workflows. bioRxiv (2021)
Go to Editor View